Investment to address growing demand in pharmaceuticals, medical devices and fast growing areas like clinical trials.

The investment will focus on enhancing infrastructure and technology across all logistics touchpoints, creating resilient, ...

DHL Group has established a DHL Health Logistics brand and announced a €2bn investment into its logistics capabilities in the ...

DHL to acquire 100% of CRYOPDP, a leading specialty courier providing logistics services for clinical trials, biopharma, and ...

CRYOPDP is a leading specialty courier providing services for clinical trials, biopharma, and cell & gene therapies.

DHL said the acquisition would enhance its capabilities in the specialty pharmaceuticals logistics arena and support the company’s strategy of becoming a leader in life science and health care ...

The acquisition fits with DHL’s strategy to become a major player in health care logistics by 2030, with an extensive temperature-controlled network, first- and last-mile specialty courier ...

The strategic partnership with Cryoport will bring together DHL's global health logistics capabilities with Cryoport's industry-leading expertise in providing specialized solutions in a fast ...